Focused Wealth Management, Inc Aeterna Zentaris Inc. Transaction History

Focused Wealth Management, Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 29, 2022	SELL	$0.33 - $0.42 $165 - $210	-500 Reduced 25.0%	1,500 $1,000
Q4 2021 Jan 31, 2022	BUY	$0.36 - $0.77 $360 - $770	1,000 Added 100.0%	2,000 $1,000
Q1 2021 May 03, 2021	SELL	$0.51 - $3.34 $510 - $3,340	-1,000 Reduced 50.0%	1,000 $1,000
Q4 2020 Feb 03, 2021	BUY	$0.3 - $0.44 $600 - $880	2,000 New	2,000 $1,000

Ticker AEZS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,855,880
Market Cap $19.4M
Description
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...

Get notified when there are updates to the investment portfolio of Focused Wealth Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Focused Wealth Management, Inc with notifications on news.